GlassScriptPhysician profile
Nicolette Lujan
NPI 1124616271
$2,326.03
in general payments reported to CMS, 2019-2025
18 companies · $2,205 in 2025
The $2,205 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $121 · 2025: $2,205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,098 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,098.08 |
| Education | $106.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $354.54 | 2025 | Farxiga, Lokelma |
| Ardelyx, INC. | $298.72 | 2025 | Ibsrela |
| Calliditas Therapeutics US INC. | $234.06 | 2025 | Tarpeyo |
| Mallinckrodt Hospital Products INC. | $228.12 | 2025 | Acthar |
| Aurinia Pharma U.S., INC. | $170.72 | 2025 | Lupkynis |
| Vifor Pharma, INC. | $165.64 | 2025 | Veltassa |
| Apellis Pharmaceuticals, INC. | $162.39 | 2025 | Empaveli |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.44 | 2025 | Jardiance |
| Ethicon US, LLC | $120.96 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.57 | 2025 | |
| Glaxosmithkline, LLC. | $96.10 | 2025 | Benlysta |
| Travere Therapeutics, INC. | $69.27 | 2025 | |
| Akebia Therapeutics INC | $48.43 | 2025 | Vafseo |
| Veloxis Pharmaceuticals, INC. | $41.33 | 2025 | Envarsus |
| Scpharmaceuticals INC. | $26.43 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $25.99 | 2025 | Purified Cortrophin Gel |
| Opko Pharmaceuticals, LLC | $24.97 | 2025 | Rayaldee |
| Otsuka America Pharmaceutical, INC. | $23.35 | 2025 | Jynarque |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicolette Lujan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.